FDA tests new program to speed drugmaker talks; Bezos-linked AI startup raises $106M

The FDA will now allow biotechs to ask agency staff for “quick clarifications” via email. Elsewhere, Novartis hiked guidance for two top drugs and a startup nearing “unicorn” status secured a megaround.